Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...
Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
“By using a ‘rule out’ initial tool in the primary care setting, we can help people who are not living with Alzheimer’s get to the root of their cognitive symptoms faster, while ensuring those who may ...
A group of researchers have identified a warning sign of Alzheimer's disease that can appear 25 years before other symptoms - ...
The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...
A group of researchers have identified a warning sign of Alzheimer's disease that can appear 25 years before other symptoms - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback